ANZUP 2017 Interviews - Michael Hofman
Nov 29, 2017•5 min
Episode description
Michael Hofman discusses the new ANZUP/PCFA trial investigating therapeutic Lutetium (Lu-177) PSMA for men with advanced mCRPC.
For the best experience, listen in Metacast app for iOS or Android
